Nowadays, there's lots of buzz about spectacular new medical treatments such as personalised cancer therapy with modified immune cells or antibodies. Such treatments, however, are very complex and ...

DNA-encoded chemical libraries (DELs) have emerged as a transformative technology in drug discovery, offering unparalleled efficiency in the identification of bioactive small molecules. By covalently ...

CHENGDU, China, July 16, 2024 /PRNewswire/ -- "Evolving DNA-Encoded Library Technology and Its Application for Innovative Drug Discovery" webinar will be jointly hosted by HitGen Inc. and Xtalks on ...

Over the past two decades, large genetic studies have linked tens of thousands of DNA variants to thousands of human traits and diseases. Yet, correcting the effects of those variants to treat disease ...

CHENGDU, China--(BUSINESS WIRE)--HitGen and Fierce Biotech jointly release the Whitepaper: Advancing Drug Discovery through DNA-Encoded Library (DEL) Technology today. This whitepaper will provide the ...

MADISON, Wis.--(BUSINESS WIRE)--A new study demonstrates how the combination of DNA-encoded libraries (DELs) and NanoBRET Target Engagement technology can accelerate early-stage drug discovery.

Straits Research released its highly anticipated report,“ Global DNA-encoded Library Market Size & Outlook, 2026-2034”. According to the study, the market size is valued at USD 851.06 million in 2025 ...

Siena (Italy), November 7 th 2022 - Philogen S.p.A., a clinical-stage biotechnology company focused on the development of innovative medicines based on tumor targeting antibodies and small molecule ...

CHENGDU, China, Nov. 13, 2022 /PRNewswire/ -- Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE:688222.SH) today announced that it has entered into a research collaboration agreement ...